Global Health's stock jumps 2% on impressive earnings
Global Health's stock rose 2% to ₹1,402.70 on Monday, landing it among the top gainers on the Nifty Midcap 150.
Investors are upbeat thanks to the company's solid earnings and steady growth.
Revenue up nearly 20% in Q1 FY26 (April-June)
In Q1 FY26 (April-June 2025), Global Health pulled in ₹1,030.84 crore in revenue—up nearly 20% from last year—and net profit soared almost 50% to ₹158.98 crore.
Over the past three years, annual revenue jumped from ₹2,166.59 crore (2022) to ₹3,692.32 crore (2025), showing real momentum.
Debt super low at 0.10
Despite all that growth, earnings per share barely moved—₹17.92 now vs ₹17.80 last year—but the company keeps its debt super low (debt-to-equity ratio: 0.10) and has a hefty market cap of about ₹37,000 crore as of September 2025.
Plus, shareholders get a final dividend payout this August—always a nice bonus!